Association between fentanyl use and virologic suppression in an HIV-infected cohort of people who use/inject drugs (PWID): results from a bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) switch study

被引:0
|
作者
Conway, B. [1 ,2 ]
Yi, S. [1 ]
Sharma, S. [1 ]
Yung, R. [1 ]
Truong, D. [1 ]
机构
[1] Vancouver Infect Dis Ctr, Vancouver, BC, Canada
[2] Simon Fraser Univ, Burnaby, BC, Canada
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P127
引用
收藏
页码:121 / 122
页数:2
相关论文
共 43 条
  • [41] Week 48 results of EMERALD: a Phase 3, randomised, non-inferiority study evaluating the efficacy and safety of switching from boosted-protease inhibitors (bPI) plus emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF) regimens to the once daily (QD), single-tablet regimen (STR) of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in virologically suppressed, HIV-1-infected adults
    Orkin, C.
    Molina, J-M
    Gallant, J.
    Negredo, E.
    Gathe, J.
    Eron, J.
    van Landuyt, E.
    Lathouwers, E.
    Hufkens, V.
    Petrovic, R.
    Opsomer, M.
    HIV MEDICINE, 2018, 19 : S32 - S32
  • [42] NEGATIVE AFFECT MODERATES THE ASSOCIATION BETWEEN AT-RISK SEXUAL BEHAVIORS AND SUBSTANCE USE DURING SEX: FINDINGS FROM A LARGE COHORT STUDY OF HIV-INFECTED MALES ENGAGED IN PRIMARY CARE IN THE US
    Mimiaga, Matthew J.
    Reisner, Sari
    Crane, Heidi
    Wilson, Johannes
    Grasso, Chris
    Safren, Steven A.
    Kitahata, Mari
    Mayer, Kenneth H.
    ANNALS OF BEHAVIORAL MEDICINE, 2012, 43 : S268 - S268
  • [43] A phase 3b, open-label, pilot study to evaluate switching to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in virologically-suppressed HIV-1 infected adult subjects harboring NRTI resistance mutations M184V/I +/- TAMs (GS-US-292-1824): week 24 results
    Perez-Valero, I.
    Llibre, J. M.
    Lazzarin, A.
    Di Perri, G.
    Pulido, F.
    Molina, J-M
    Esser, S.
    Margot, N.
    Shao, Y.
    Piontkowsky, D.
    Das, M.
    McNicholl, I.
    Haubrich, R.
    HIV MEDICINE, 2019, 20 : 170 - 171